405 related articles for article (PubMed ID: 30738865)
1. Mechanisms of PTEN loss in cancer: It's all about diversity.
Álvarez-Garcia V; Tawil Y; Wise HM; Leslie NR
Semin Cancer Biol; 2019 Dec; 59():66-79. PubMed ID: 30738865
[TBL] [Abstract][Full Text] [Related]
2. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.
Carnero A; Blanco-Aparicio C; Renner O; Link W; Leal JF
Curr Cancer Drug Targets; 2008 May; 8(3):187-98. PubMed ID: 18473732
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer, PI3K, PTEN and prognosis.
Wise HM; Hermida MA; Leslie NR
Clin Sci (Lond); 2017 Feb; 131(3):197-210. PubMed ID: 28057891
[TBL] [Abstract][Full Text] [Related]
4. PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.
Haddadi N; Lin Y; Travis G; Simpson AM; Nassif NT; McGowan EM
Mol Cancer; 2018 Feb; 17(1):37. PubMed ID: 29455665
[TBL] [Abstract][Full Text] [Related]
5. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
6. PTEN loss in the continuum of common cancers, rare syndromes and mouse models.
Hollander MC; Blumenthal GM; Dennis PA
Nat Rev Cancer; 2011 Apr; 11(4):289-301. PubMed ID: 21430697
[TBL] [Abstract][Full Text] [Related]
7. The multiple layers of non-genetic regulation of PTEN tumour suppressor activity.
Correia NC; Gírio A; Antunes I; Martins LR; Barata JT
Eur J Cancer; 2014 Jan; 50(1):216-25. PubMed ID: 24054978
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors.
Philip CA; Laskov I; Beauchamp MC; Marques M; Amin O; Bitharas J; Kessous R; Kogan L; Baloch T; Gotlieb WH; Yasmeen A
BMC Cancer; 2017 Sep; 17(1):638. PubMed ID: 28886696
[TBL] [Abstract][Full Text] [Related]
9. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.
Cully M; You H; Levine AJ; Mak TW
Nat Rev Cancer; 2006 Mar; 6(3):184-92. PubMed ID: 16453012
[TBL] [Abstract][Full Text] [Related]
10. PI(3)king apart PTEN's role in cancer.
Zhang S; Yu D
Clin Cancer Res; 2010 Sep; 16(17):4325-30. PubMed ID: 20622047
[TBL] [Abstract][Full Text] [Related]
11. The biology and clinical relevance of the PTEN tumor suppressor pathway.
Sansal I; Sellers WR
J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063
[TBL] [Abstract][Full Text] [Related]
12. The functions and regulation of the PTEN tumour suppressor.
Song MS; Salmena L; Pandolfi PP
Nat Rev Mol Cell Biol; 2012 Apr; 13(5):283-96. PubMed ID: 22473468
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic and Therapeutic Targeting of PTEN Loss in Bone Malignancies.
Xi Y; Chen Y
J Cell Biochem; 2015 Sep; 116(9):1837-47. PubMed ID: 25773992
[TBL] [Abstract][Full Text] [Related]
15. Tenets of PTEN tumor suppression.
Salmena L; Carracedo A; Pandolfi PP
Cell; 2008 May; 133(3):403-14. PubMed ID: 18455982
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of cancers with loss of PTEN function.
Dillon LM; Miller TW
Curr Drug Targets; 2014 Jan; 15(1):65-79. PubMed ID: 24387334
[TBL] [Abstract][Full Text] [Related]
17. The PTEN tumor suppressor gene and its role in lymphoma pathogenesis.
Wang X; Huang H; Young KH
Aging (Albany NY); 2015 Dec; 7(12):1032-49. PubMed ID: 26655726
[TBL] [Abstract][Full Text] [Related]
18. The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer.
Turnham DJ; Bullock N; Dass MS; Staffurth JN; Pearson HB
Cells; 2020 Oct; 9(11):. PubMed ID: 33105713
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of PTEN loss in prostate cancer.
Jamaspishvili T; Berman DM; Ross AE; Scher HI; De Marzo AM; Squire JA; Lotan TL
Nat Rev Urol; 2018 Apr; 15(4):222-234. PubMed ID: 29460925
[TBL] [Abstract][Full Text] [Related]
20. Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus.
Snaddon J; Parkinson EK; Craft JA; Bartholomew C; Fulton R
Br J Cancer; 2001 Jun; 84(12):1630-4. PubMed ID: 11401316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
